立入検査 Records in Japan
Browse Japanese administrative enforcement records classified as 立入検査. Each record includes the company, governing law, issuing authority, penalty amount when available, and a link to the original Japanese government disclosure.
Useful for long-tail searches such as "立入検査 Japan company", "Japanese administrative 立入検査", and "Japan regulatory sanctions by action type".
3 Japanese enforcement records
Japanese version| Date | Company | Law | Action | Penalty | Authority |
|---|---|---|---|---|---|
| 4 Sept 2023 | 株式会社メディファーマ The Ministry of Health, Labour and Welfare conducted an on-site inspection of Medipharm Corporation on September 4, 2023, and identified violations of GCP standards, including data falsification and improper conduct during clinical trials. | 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律（昭和35年法律第145号） | 立入検査 | - | Ministry of Health, Labour and Welfare |
| 30 Aug 2023 | 株式会社メディファーマ The Ministry of Health, Labour and Welfare conducted an on-site inspection of Medipharm Corporation on August 30, 2023, and identified violations of GCP standards in clinical trial operations, including data falsification and improper conduct. | 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律（昭和35年法律第145号） | 立入検査 | - | Ministry of Health, Labour and Welfare |
| 29 Aug 2023 | 株式会社メディファーマ Medipharm Co., Ltd. was found to have violated GCP in clinical trial operations commissioned from medical institutions, including data falsification. | 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律（昭和35年法律第145号） | 立入検査 | - | Ministry of Health, Labour and Welfare |